Shared Research logo
  • Home
  • All Companies
    All Companies
    Companies
    Recently viewed
    Browse companies...
  • English日本語
  • Log in
  • Sign up
Overview
My Comments
My Notes
Kringle Pharma

Kringle Pharma 4884

クリングルファーマ
Kringle Pharma, Inc.
Recent Updates
2022-07-04
Collaborative research agreement for applied research using HGF
2022-07-04
1H FY09/22 report update
2022-06-30
Recombinant human HFG for acute spinal cord injury selected as a FY2022 recipient of Orphan Products Development Support Program grant
Get in touch
207 Saito Bio Incubator 7-7-15 Saitoasagi, Ibaraki, OSAKA 567-0085, JAPAN
https://www.kringle-pharma.com/
Summary
Kringle Pharma, Inc. is a late clinical-stage biopharmaceutical company. It was founded as a biotech startup in Osaka in December 2001, and traces its roots back to Osaka University. Kringle’s mission is to develop and commercialize innovative medicines for patients suffering from intractable diseases. Its current research and development focus is on the application of recombinant human hepatocyte growth factor (HGF) to treat patients with these rare diseases worldwide.
Biotechnology
Key dates
2021-06-21
Coverage initiation